Omeprazole and Leukopenia for Women aged 40-49 (a phase IV clinical study of FDA data)
Summary:
Leukopenia is found for women aged 40-49 who take Omeprazole (omeprazole). This study is created by eHealthMe based on reports of 18,029 women aged 40-49 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:
- Time on Omeprazole when people have Leukopenia
- Top conditions
- Top co-used drugs
- Top other side effects
18,029 women aged 40-49 reported to have side effects when taking Omeprazole.
Among them, 80 people (0.44%) have Leukopenia
What is Omeprazole?
Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.
What is Leukopenia?
Leukopenia (less number of white blood cells in blood) is found to be associated with 1,683 drugs and 2,290 conditions by eHealthMe. Check the latest studies of Leukopenia.
Number of reports submitted per year:

Time on Omeprazole when people have Leukopenia *
- < 1 month: 83.33 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 16.67 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Severity of Leukopenia
n/aHow people recovered from Leukopenia
n/aTop conditions involved for these people *:
You may use this to check any potential undetected conditions.
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 10 people, 12.50%
- Pain: 9 people, 11.25%
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 8 people, 10.00%
- Ovarian Cancer (cancer of ovary): 7 people, 8.75%
- Sedation: 6 people, 7.50%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 7.50%
- Breast Cancer Metastatic: 6 people, 7.50%
- Hiv Infection: 5 people, 6.25%
- Headache (pain in head): 5 people, 6.25%
- White Blood Cell Count Increased: 3 people, 3.75%
Top co-used drugs for these people *:
You may use this to check any potential interacting drugs.
- Faslodex: 6 people, 7.50%
- Paracetamol: 6 people, 7.50%
- Folic Acid: 5 people, 6.25%
- Bactrim: 5 people, 6.25%
- Gilenya: 5 people, 6.25%
- Kisqali: 5 people, 6.25%
- Gabapentin: 5 people, 6.25%
- Clozaril: 5 people, 6.25%
- Fulvestrant: 5 people, 6.25%
- Myfortic: 4 people, 5.00%
Top other side effects for these people *:
You may use this to check any potential undetected side effects.
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 39 people, 48.75%
- Fever: 21 people, 26.25%
- Nausea (feeling of having an urge to vomit): 19 people, 23.75%
- Thrombocytopenia (decrease of platelets in blood): 17 people, 21.25%
- White Blood Cell Count Decreased: 14 people, 17.50%
- Anaemia (lack of blood): 14 people, 17.50%
- Nausea And Vomiting: 13 people, 16.25%
- Headache (pain in head): 11 people, 13.75%
- Diarrhea: 10 people, 12.50%
- Fatigue (feeling of tiredness): 10 people, 12.50%
* Approximation only. Some reports may have incomplete information.
Do you take Omeprazole and have Leukopenia?
- Check whether Leukopenia is associated with a drug or a condition- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies:
How the study uses the data?
The study is based on (applicable) gender, age, omeprazole (the active ingredients of Omeprazole) and Omeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Cimetidine and Astelin - 4 seconds ago
- Drug interactions of Thorazine and Cymbalta - 9 seconds ago
- Catapres and Immunodeficiency for Women aged 30-39 - 11 seconds ago
- Could Etodolac cause Blindness? - 16 seconds ago
- Zolpidem and Xarelto drug interactions for women aged 60+ - 27 seconds ago
- Breast Cancer Female and Heart Rate Increased - 27 seconds ago
- Vancomycin and Pulmonary Oedema for Men aged 60+ - 33 seconds ago
- Could Kisqali cause Seizures? - 37 seconds ago
- Nasal Congestion in Loratadine, how severe and when it was recovered? - 54 seconds ago
- Drug interactions of Questran and Centrum Silver - a minute ago